Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis

Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis

Background: Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. The cause of multiple sclerosis is unknown but there are several evidences that associate the genetic basis of the disease with environmental causes. An important association between viral...

Full description

Bibliographic Details
Main Authors: Marta Corsetti, Gabriella Ruocco, Serena Ruggieri, Claudio Gasperini, Luca Battistini, Elisabetta Volpe
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:International Journal of Molecular Sciences
Subjects:
multiple sclerosis
myeloid dendritic cells
plasmacytoid dendritic cells
costimulatory molecules
virus infection
Toll-like receptors
Resiquimod
Online Access:https://www.mdpi.com/1422-0067/20/11/2811

Internet

https://www.mdpi.com/1422-0067/20/11/2811

Similar Items